Meanwhile, Kirsten Higgens, who funded the study added: “We’re delighted to be able to support the Exeter team to explore the application of genomics data in a more targeted approach to prostate cancer detection. It’s very exciting to see the real world benefit to patients of this innovative new approach.”
This isn’t the first time in 2022, that a new diagnostic tool for prostate cancer has been trialled out. Earlier this year, the charity Prostate Cancer UK launched their 30-second checker.
A three question questionnaire which takes around 30 seconds to complete, the online test provides men with their risk level; if their risk is above a certain point the site recommends to them a blood test which can be taken to establish their risk.
Unlike other male cancer campaigns, this promotional occurred outside of autumn, a time when much noise is made in the build-up to November and “Movember” when men grow out their moustaches to raise awareness of cancer.
READ MORE: Dementia: The speech issue frequently seen with atypical dementia
